Clinical Trials Search Tool

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 50-80

Enrollment Opens: 09-01-2021

Enrollment Closes: TBD


This trial is enrolling individuals with two copies of the E4 gene variant. This trial is called the APOLLOE, and is sponsored by Alzheon Inc. in collaboration with the National Institute on Aging (NIA). For more information, please visit

Study ID: ALZ-801-AD301

To Enroll: Call 503-476-9788 or schedule your free over-the-phone memory screen here:

Posted by: Center for Cognitive Health |